• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Diabetes: Do smartphones fit the bill for the next mobile artificial pancreas? | MassDevice.com On Call

Diabetes: Do smartphones fit the bill for the next mobile artificial pancreas? | MassDevice.com On Call

August 16, 2013 By Sony Salzman

MassDevice On Call

MASSDEVICE ON CALL — Smartphones are capable of meeting all the criteria for an artificial pancreas by providing close-loop, outpatient control of glucose levels for diabetics, according to a new study published by the American Diabetes Assn.

Using modified Android phones, researchers proved that it is possible to make an artificial pancreas fully mobile. They hope to replace the current standard, which is a laptop connected to to the patient’s glucose monitor and insulin pump, according to MobiHealthNews.

The artificial pancreas has been called the “holy grail” of the medical device industry, seamlessly providing diabetic patients with blood glucose monitoring and insulin dosing, but no such devices have made it to the U.S. market. That’s not for lack of trying, however.

Companies like Medtronic (NYSE:MDT) are slowly progressing with its research and development, with Medtronic in particular recently touting positive outcomes for its MiniMed mechanical insulin pump system. Canadian researchers have been comparing their dual-hormone artificial pancreas to conventional diabetes management with positive results.

Many companies and research groups have their eye on that "holy grail," and future iterations of the devices may be able to rely on the smartphones everyone already has in their pockets to manage the system.

 Black box warnings do little to slow dialysis drug use
Despite an FDA "black box" warning on ESA dialysis drugs, which can increase risk of heart attack and stroke, a new study finds the real reason the use of these drugs has dropped is because of a change in Medicare payments. Researchers concluded that ESA-use has been slowly dropping since a 2011 Medicare rule that removed financial incentives for big doses. There was no similar drop in ESA prescriptions following the black box labeling.
Read more

 New CT scan cuts radiation exposure by 31%, study says
Although CT scans are often necessary to map heart and other organ problems, they expose patients to potentially unsafe radiation. Researchers say that hospitals that adopt new CT hardware and software that will cut a patient’s radiation exposure by 31% without sacrificing image quality. Michigan researchers measured radiation doses of almost 12,000 patients, scanned both with the old technology and the new, at 1-year intervals. The 1st scan exposed patients to an average radiation dose of 9.5 mSV, and the 2nd an average of 6.6 mSV.
Read more

 Low-income countries still have low cervical cancer screening rates
Cervical cancer is an easily detected and highly preventable disease, yet screening rates in low- and middle-income countries are still far below higher-income countries. Approximately 53 out of 100,000 women in sub-Saharan Africa develop cervical cancer, compared to 7 out of 100,000 women in Western countries, a study said. Lead author Ruby Singhrao outlined 4 main reasons cervical cancer screenings need to be emphasized in the 2015 Millennium Development Goals.
Read more

 FDA hands Harvard $5.6M to develop its organ-on-a-chip technology
Harvard’s Wyss Institute just landed a $5.6 million contract from the FDA to continue developing its organ-on-a-chip technology, a promising new breakthrough that mimics the functions of a human organ to eliminate risks of human testing. The contract asks Wyss researchers to look into treatments for radiation sickness. The researchers are developing chip versions of the human lung, gut and bone marrow to subject them to radiation damage and evaluate possible treatments.
Read more

Filed Under: Digital Health, News Well, Oncology Tagged With: American Diabetes Assn., Dialysis, Insulin Management, On Call

More recent news

  • Breaking: Sequel to launch twiist automated insulin delivery system next month
  • Dexcom shares U.S. report on CGM benefits for type 2 diabetes
  • Data backs Medtronic MiniMed 780G for type 2, children as company seeks expanded indications
  • Endogenex data supports type 2 diabetes procedure
  • Ambu wins FDA clearance for first single-use cysto-nephroscope

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy